Find A Physician

Return to Dr. Jeffrey Moses Assumes Expanded Role in Interventional Cardiology, Leading New Bi-Campus Program at NewYork-Presbyterian Hospital Overview

More on Dr. Jeffrey Moses Assumes Expanded Role in Interventional Cardiology, Leading New Bi-Campus Program at NewYork-Presbyterian Hospital

Research and Clinical Trials

Return to Dr. Jeffrey Moses Assumes Expanded Role in Interventional Cardiology, Leading New Bi-Campus Program at NewYork-Presbyterian Hospital Overview

More on Dr. Jeffrey Moses Assumes Expanded Role in Interventional Cardiology, Leading New Bi-Campus Program at NewYork-Presbyterian Hospital

Dr. Jeffrey Moses Assumes Expanded Role in Interventional Cardiology, Leading New Bi-Campus Program at NewYork-Presbyterian Hospital

New Program Is Among Nation's Largest, Encompassing Two Major Medical Centers: NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Weill Cornell

NEW YORK (Oct 22, 2010)

Dr. Jeffrey W. Moses, an internationally recognized leader in clinical innovation and research, is assuming an expanded role as director of interventional cardiology at NewYork–Presbyterian Hospital. The new program spans the Hospital's two major medical centers — NewYork–Presbyterian Hospital/Columbia University Medical Center and NewYork–Presbyterian Hospital/Weill Cornell Medical Center.

In his new role, Dr. Moses will oversee one of the largest interventional cardiology programs in the country, with more than 5,000 cases in a year. Since 2004, Dr. Moses has served as director of the Center for Interventional Vascular Therapy and director of the Cardiac Catheterization Lab at NewYork–Presbyterian Hospital/Columbia University Medical Center. He is professor of medicine at Columbia University College of Physicians and Surgeons. He also holds a faculty appointment at Weill Cornell Medical College.

"As the university hospital of two of the country's top medical schools — Columbia University College of Physicians and Surgeons and Weill Cornell Medical College — NewYork–Presbyterian Hospital is uniquely positioned to offer patients the benefits of clinical research and the latest developments in diagnosis and treatment. Jeff Moses' new role will expand and strengthen our ability to do this in the field of interventional cardiology," says Dr. Herbert Pardes, president and CEO of NewYork–Presbyterian Hospital.

"Dr. Moses has built an outstanding program in interventional cardiology. By expanding this program so that it covers both NewYork–Presbyterian/Columbia in Upper Manhattan and NewYork–Presbyterian/Weill Cornell on the Upper East Side, we will be able to bring a broad array of resources to bear to offer patients the most advanced minimally invasive treatments for cardiovascular conditions," says Dr. Steven J. Corwin, executive vice president and COO of NewYork–Presbyterian Hospital.

"We are thrilled to welcome Dr. Moses to the Department of Medicine," says Dr. Andrew I. Schafer, physician–in–chief at NewYork–Presbyterian Hospital/Weill Cornell Medical Center; and chairman of the Department of Medicine and the E. Hugh Luckey Distinguished Professor of Medicine at Weill Cornell Medical College. "Throughout his career, Dr. Moses has set the standard of care for interventional cardiology, and we expect that record of innovation to continue here at NewYork–Presbyterian/Weill Cornell."

"I look forward to working alongside my colleagues at NewYork–Presbyterian/Weill Cornell as we realize the benefits of new minimally invasive treatment options such as drug–eluting stents and percutaneous valves," says Dr. Moses.

Dr. Moses has performed more than 15,000 interventional procedures and pioneered innovative treatment approaches using minimally invasive surgery, angioplasty, stents, gene therapy, support devices and percutaneous valves. He has also made significant contributions to clinical research and education in the area of interventional vascular therapy.

Dr. Moses was involved with the first clinical trial of a stent (STRESS trial, 1993). In the mid–1990s, he was part of an early trial looking at treating heart attack with angioplasty (PAMI trial). He was the principal investigator of the first drug–eluting stent trial in the U.S., leading to FDA approval of the first drug–eluting stent in 2003 (SIRIUS trial). In recent years, Dr. Moses has participated in studies involving stenting of complex coronary lesions, and he currently serves on the executive committee of the PARTNER clinical trial, a multicenter study of a transcatheter aortic valve. The innovative approach replaces heart valves without open–heart surgery. Recently published data has demonstrated that transcather aortic–valve implementation, compared with standard therapy, resulted in lower rates of death among patients who cannot undergo surgery for aortic stenosis.

He is the author of more than 300 peer–reviewed articles, book chapters and reviews. He serves on the board of directors of the Cardiovascular Research Foundation, a nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education.

Dr. Moses joined NewYork–Presbyterian in 2004. Prior to that, he was chief of interventional cardiology at Lenox Hill Hospital and held a professorship in clinical medicine at New York University School of Medicine. He also served in various positions in interventional cardiology and electrophysiology at the former New York Hospital–Cornell Medical Center (today NewYork–Presbyterian/Weill Cornell). Dr. Moses received his bachelor's degree from Yale and his medical degree from the University of Pennsylvania School of Medicine. He did his internship, residency and fellowship training in cardiology at the University of Pennsylvania Medical Center.

For more information, patients may call (866) NYP–NEWS.

NewYork–Presbyterian Hospital

NewYork–Presbyterian Hospital, based in New York City, is the nation's largest not–for–profit, non–sectarian hospital, with 2,353 beds. The Hospital has nearly 2 million inpatient and outpatient visits in a year, including more than 220,000 visits to its emergency departments — more than any other area hospital. NewYork–Presbyterian provides state–of–the–art inpatient, ambulatory and preventive care in all areas of medicine at five major centers: NewYork–Presbyterian Hospital/Weill Cornell Medical Center, NewYork–Presbyterian Hospital/Columbia University Medical Center, NewYork–Presbyterian/Morgan Stanley Children's Hospital, NewYork–Presbyterian/The Allen Hospital and NewYork–Presbyterian Hospital/Westchester Division. One of the most comprehensive health care institutions in the world, the Hospital is committed to excellence in patient care, research, education and community service. NewYork–Presbyterian is the #1 hospital in the New York metropolitan area and is consistently ranked among the best academic medical institutions in the nation, according to U.S.News & World Report. The Hospital has academic affiliations with two of the nation's leading medical colleges: Weill Cornell Medical College and Columbia University College of Physicians and Surgeons. For more information, visit www.nyp.org.

Contact

Jennifer Homa
Phone: (212) 305-5587.
jeh9057@nyp.org
  • Bookmark
  • Print

    Find a Doctor

Click the button above or call
1 877 NYP WELL






Top of page